Sarizotan
id:
sarizotan-185-2641214
title:
Sarizotan
text:
Sarizotan (EMD-128,130) is a selective 5-HT1A receptor agonist and D2 receptor antagonist, which has antipsychotic effects, and has also shown efficacy in reducing dyskinesias resulting from long-term anti-Parkinsonian treatment with levodopa. In June 2006, the developer Merck KGaA announced that the development of sarizotan was discontinued, after two sarizotan Phase III studies failed to meet the primary efficacy endpoint and neither the Phase II findings nor the results from preclinical studi
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Sarizotan
date created:
2010-03-21T09:50:06Z
date modified:
2024-09-07T15:19:42Z
main entity:
{"identifier":"Q7424144","url":"https://www.wikidata.org/entity/Q7424144"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/80/Sarizotan_Structure.svg","width":900,"height":310}
fields total:
13
integrity:
16